The Effect of a Ketogenic Diet on the Exercise Induced Immune Response
NCT ID: NCT04019730
Last Updated: 2019-12-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2018-10-10
2019-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low carbohydrate diet
less than 10 En% carbohydrates
diet
low carbohydrate diet (\< 10 EN% carbs) vs high carbohydrate diet (\>50 EN% carbs)
high carbohydrate diet
more than 50 En%carbohydrates
diet
low carbohydrate diet (\< 10 EN% carbs) vs high carbohydrate diet (\>50 EN% carbs)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diet
low carbohydrate diet (\< 10 EN% carbs) vs high carbohydrate diet (\>50 EN% carbs)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18 - 45 y
* BMI: 18.5 - 25 kg/m2
* Hb ≥ 8.5 mmol/L, determined with blood sample from finger tip
* Minimal of 3 hours of training per week, and a maximum of 10 hours
* DKTP (diphtheria, pertussis, tetanus and polio) vaccinated (for stimulation of isolated cells (PBMC's) with tetanus toxoid)
* No asthma medication and/or anti-inflammatory medication
* No use of immunosuppressive medication
* No flu and/or travel vaccinations in the 4 months before and during the study
* Able to be present and participate at all test days
* Willing and able to follow prescribed 2 times a diet for 2 weeks in a row
Exclusion Criteria
* Food allergies (e.g. nuts, gluten, avocado)
* Vegetarian diet
* Blood donations during study or in the 2 months prior to the study
* Use of immunosuppressive medication
* Flu and/or travel vaccination 4 months before and during the study
* Hb \< 8.5 mmol/L
* Working at "Human Nutrition" - Wageningen University
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wageningen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Mensink, Dr
Role: STUDY_DIRECTOR
Wageningen University and Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Human Nutrition, Wageningen University
Wageningen, Gelderland, Netherlands
Wageningen University and research
Wageningen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL6540408118
Identifier Type: -
Identifier Source: org_study_id